Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: Value of positron emission tomography in diagnosis

Rajesh R. Patel, Rathan M. Subramaniam, Jaywant N. Mandrekar, Julie E. Hammack, Val J. Lowe, James R. Jett

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

OBJECTIVE: To determine the value of positron emission tomography (PET) in diagnosing occult malignancies in patients with paraneoplastic neurologic syndromes (PNSs) at Mayo Clinic's site in Rochester, MN. PATIENTS AND METHODS: We retrospectively reviewed the medical charts of all 107 patients who underwent PET from January 1, 2000, to July 31, 2006, for the indication of suspected PNS. Three patients did not meet inclusion criteria. PET results were considered positive if increased fludeoxyglucose F 18 uptake indicated malignancy (24 patients). Results from computed tomography were interpreted as positive if any suspect lesion was consistent with malignancy (26 patients). RESULTS: One hundred four patients with PNS were identified from the PET central database; 73 patients had at least 1 positive result for paraneoplastic antibody, and 31 had antibody-negative PNS. Malignancy was confirmed pathologically in 10 patients, of whom 8 had positive PET results. There were 2 cases of confirmed malignancy (fallopian tube adenocarcinoma and spindle cell uterine carcinoma) for which PET results were negative. Two patients with positive PET results declined biopsy. Computed tomography was able to identify 3 of the 10 malignancies detected. Five cases of malignancy were detected only by PET. All patients with confirmed malignancy had positive results for at least 1 paraneoplastic antibody. One patient with positive results for PNS antibody and negative PET results was diagnosed as having small cell carcinoma on a follow-up PET scan after 27 months. PET had sensitivity, specificity, positive predictive value, and negative predictive value of 80%, 67%, 53%, and 88%, respectively. CONCLUSION: PET scan was shown to be more sensitive than computed tomography for detecting occult malignancy (confirmed by positive test results for autoantibody) among patients with suspected PNS. The greatest clinical utility of PET could be in its high negative predictive value.

Original languageEnglish (US)
Pages (from-to)917-922
Number of pages6
JournalMayo Clinic Proceedings
Volume83
Issue number8
DOIs
StatePublished - Jan 1 2008

Fingerprint

Nervous System Paraneoplastic Syndromes
Positron-Emission Tomography
Neoplasms
Antibodies
Tomography
Small Cell Carcinoma
Fallopian Tubes
Fluorodeoxyglucose F18

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Occult malignancy in patients with suspected paraneoplastic neurologic syndromes : Value of positron emission tomography in diagnosis. / Patel, Rajesh R.; Subramaniam, Rathan M.; Mandrekar, Jaywant N.; Hammack, Julie E.; Lowe, Val J.; Jett, James R.

In: Mayo Clinic Proceedings, Vol. 83, No. 8, 01.01.2008, p. 917-922.

Research output: Contribution to journalArticle

Patel, Rajesh R. ; Subramaniam, Rathan M. ; Mandrekar, Jaywant N. ; Hammack, Julie E. ; Lowe, Val J. ; Jett, James R. / Occult malignancy in patients with suspected paraneoplastic neurologic syndromes : Value of positron emission tomography in diagnosis. In: Mayo Clinic Proceedings. 2008 ; Vol. 83, No. 8. pp. 917-922.
@article{7130da823d174631b53585a28f4b4ce6,
title = "Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: Value of positron emission tomography in diagnosis",
abstract = "OBJECTIVE: To determine the value of positron emission tomography (PET) in diagnosing occult malignancies in patients with paraneoplastic neurologic syndromes (PNSs) at Mayo Clinic's site in Rochester, MN. PATIENTS AND METHODS: We retrospectively reviewed the medical charts of all 107 patients who underwent PET from January 1, 2000, to July 31, 2006, for the indication of suspected PNS. Three patients did not meet inclusion criteria. PET results were considered positive if increased fludeoxyglucose F 18 uptake indicated malignancy (24 patients). Results from computed tomography were interpreted as positive if any suspect lesion was consistent with malignancy (26 patients). RESULTS: One hundred four patients with PNS were identified from the PET central database; 73 patients had at least 1 positive result for paraneoplastic antibody, and 31 had antibody-negative PNS. Malignancy was confirmed pathologically in 10 patients, of whom 8 had positive PET results. There were 2 cases of confirmed malignancy (fallopian tube adenocarcinoma and spindle cell uterine carcinoma) for which PET results were negative. Two patients with positive PET results declined biopsy. Computed tomography was able to identify 3 of the 10 malignancies detected. Five cases of malignancy were detected only by PET. All patients with confirmed malignancy had positive results for at least 1 paraneoplastic antibody. One patient with positive results for PNS antibody and negative PET results was diagnosed as having small cell carcinoma on a follow-up PET scan after 27 months. PET had sensitivity, specificity, positive predictive value, and negative predictive value of 80{\%}, 67{\%}, 53{\%}, and 88{\%}, respectively. CONCLUSION: PET scan was shown to be more sensitive than computed tomography for detecting occult malignancy (confirmed by positive test results for autoantibody) among patients with suspected PNS. The greatest clinical utility of PET could be in its high negative predictive value.",
author = "Patel, {Rajesh R.} and Subramaniam, {Rathan M.} and Mandrekar, {Jaywant N.} and Hammack, {Julie E.} and Lowe, {Val J.} and Jett, {James R.}",
year = "2008",
month = "1",
day = "1",
doi = "10.4065/83.8.917",
language = "English (US)",
volume = "83",
pages = "917--922",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Occult malignancy in patients with suspected paraneoplastic neurologic syndromes

T2 - Value of positron emission tomography in diagnosis

AU - Patel, Rajesh R.

AU - Subramaniam, Rathan M.

AU - Mandrekar, Jaywant N.

AU - Hammack, Julie E.

AU - Lowe, Val J.

AU - Jett, James R.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - OBJECTIVE: To determine the value of positron emission tomography (PET) in diagnosing occult malignancies in patients with paraneoplastic neurologic syndromes (PNSs) at Mayo Clinic's site in Rochester, MN. PATIENTS AND METHODS: We retrospectively reviewed the medical charts of all 107 patients who underwent PET from January 1, 2000, to July 31, 2006, for the indication of suspected PNS. Three patients did not meet inclusion criteria. PET results were considered positive if increased fludeoxyglucose F 18 uptake indicated malignancy (24 patients). Results from computed tomography were interpreted as positive if any suspect lesion was consistent with malignancy (26 patients). RESULTS: One hundred four patients with PNS were identified from the PET central database; 73 patients had at least 1 positive result for paraneoplastic antibody, and 31 had antibody-negative PNS. Malignancy was confirmed pathologically in 10 patients, of whom 8 had positive PET results. There were 2 cases of confirmed malignancy (fallopian tube adenocarcinoma and spindle cell uterine carcinoma) for which PET results were negative. Two patients with positive PET results declined biopsy. Computed tomography was able to identify 3 of the 10 malignancies detected. Five cases of malignancy were detected only by PET. All patients with confirmed malignancy had positive results for at least 1 paraneoplastic antibody. One patient with positive results for PNS antibody and negative PET results was diagnosed as having small cell carcinoma on a follow-up PET scan after 27 months. PET had sensitivity, specificity, positive predictive value, and negative predictive value of 80%, 67%, 53%, and 88%, respectively. CONCLUSION: PET scan was shown to be more sensitive than computed tomography for detecting occult malignancy (confirmed by positive test results for autoantibody) among patients with suspected PNS. The greatest clinical utility of PET could be in its high negative predictive value.

AB - OBJECTIVE: To determine the value of positron emission tomography (PET) in diagnosing occult malignancies in patients with paraneoplastic neurologic syndromes (PNSs) at Mayo Clinic's site in Rochester, MN. PATIENTS AND METHODS: We retrospectively reviewed the medical charts of all 107 patients who underwent PET from January 1, 2000, to July 31, 2006, for the indication of suspected PNS. Three patients did not meet inclusion criteria. PET results were considered positive if increased fludeoxyglucose F 18 uptake indicated malignancy (24 patients). Results from computed tomography were interpreted as positive if any suspect lesion was consistent with malignancy (26 patients). RESULTS: One hundred four patients with PNS were identified from the PET central database; 73 patients had at least 1 positive result for paraneoplastic antibody, and 31 had antibody-negative PNS. Malignancy was confirmed pathologically in 10 patients, of whom 8 had positive PET results. There were 2 cases of confirmed malignancy (fallopian tube adenocarcinoma and spindle cell uterine carcinoma) for which PET results were negative. Two patients with positive PET results declined biopsy. Computed tomography was able to identify 3 of the 10 malignancies detected. Five cases of malignancy were detected only by PET. All patients with confirmed malignancy had positive results for at least 1 paraneoplastic antibody. One patient with positive results for PNS antibody and negative PET results was diagnosed as having small cell carcinoma on a follow-up PET scan after 27 months. PET had sensitivity, specificity, positive predictive value, and negative predictive value of 80%, 67%, 53%, and 88%, respectively. CONCLUSION: PET scan was shown to be more sensitive than computed tomography for detecting occult malignancy (confirmed by positive test results for autoantibody) among patients with suspected PNS. The greatest clinical utility of PET could be in its high negative predictive value.

UR - http://www.scopus.com/inward/record.url?scp=49249137501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49249137501&partnerID=8YFLogxK

U2 - 10.4065/83.8.917

DO - 10.4065/83.8.917

M3 - Article

C2 - 18674476

AN - SCOPUS:49249137501

VL - 83

SP - 917

EP - 922

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -